Parkinsons disease review unveil that key players are focusing on therapeutics development

Report: Parkinson's Disease - Pipeline Review, H1 2014

Category: Healthcare

www.researchonglobalmarkets.com

Insert ImageHeight - 3.60Width – 4.98

http://bit.ly/parkinson-2014

http://www.researchonindia.com/

http://www.researchonindia.com/

http://www.researchonglobalmarkets.com/


https://www.facebook.com/pages/Research-on-Global-Markets/536186973101152


http://www.linkedin.com/groups?gid=5131467&mostPopular=&trk=tyah


https://twitter.com/researchonglobe



• A snapshot of the global therapeutic landscape of Parkinson's

Disease

• Review of key pipeline products under drug profile section

• Review of key players involved in the therapeutics development for

Parkinson's Disease enlisting all their major and minor projects

• Summary of all the dormant and discontinued pipeline projects

• Review of the Parkinson's Disease products under development by

companies and universities or research institutes based on

information derived from company and industry-specific sources

Report Coverage












• Pipeline products coverage based on various stages of development

ranging from pre-registration till discovery and undisclosed stages

• Detailed assessment of monotherapy and combination therapy

pipeline projects

• Coverage of the Parkinson's Disease pipeline on the basis of target,

MoA, route of administration and molecule type

• Latest news and deals relating related to pipeline products

Report Coverage (Continued)












• Strategically significant competitor information, analysis, and insights

assist to formulate effective R&D development strategies

• Identify emerging players with potentially strong product portfolio

and create effective counter-strategies to gain competitive advantage

• Develop strategic initiatives by understanding the focus areas of

leading companies

• Identify and understand important and diverse types of therapeutics

under development for Parkinson's Disease

• Plan mergers and acquisitions effectively by identifying key players of

the most promising pipeline

Report Benefits












• Devise corrective measures for pipeline projects by understanding

Parkinson's Disease pipeline depth and focus of Indication

therapeutics

• Develop and design in-licensing and out-licensing strategies by

identifying prospective partners with the most attractive projects to

enhance and expand business potential and scope

• Modify the therapeutic portfolio by identifying discontinued projects

and understanding the factors that drove them from pipeline

Report Benefits (Continued)












Table of Contents

• Introduction

• Parkinson's Disease Overview

• Therapeutics Development

• Drug Profiles

• Appendix












• Publish date: Feb 28, 2014

• Number of slides: 775

• Geographic coverage: Global

• Available format: PDF, CD, Hardcopy

• Price for Single User License: USD 2,500

• Price for Site License: USD 5,000

• Price for Global User License: USD 7,500

• Delivery Time: Within 1 business day

• Payment Modes: Credit/Debit Card, RTGS/Wire Transfer, Google

Wallet, PayPal

Report Details












Interested in this report?

About UsResearch on Global Markets is a leading source for market research on various sectors globally offering premium research content from worldwide publishers of market research reports

For further information, get in touch with us:

E-mail: [email protected]: US: +1 866 325 7446 UK: +44 203 514 2363 Others: +91 22 4098 7600

Industry Segments

Automotive & Transport Consumer goods Agriculture

Food and Beverage Energy and Utilities Public Sector

Manufacturing & Construction Healthcare Media & Entertainment

IT, Telecom & Electronics Services Others

To view more details regarding this premium market research report,Please click here










Documents

Parkinsons disease review unveil that key players are focusing on therapeutics development